A detailed history of High Tower Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 34,739 shares of MRNA stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,739
Previous 48,779 28.78%
Holding current value
$1.4 Million
Previous $5.79 Million 59.93%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$63.64 - $125.14 $893,505 - $1.76 Million
-14,040 Reduced 28.78%
34,739 $2.32 Million
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $1.36 Million - $2.23 Million
-13,397 Reduced 21.55%
48,779 $5.79 Million
Q1 2024

May 06, 2024

BUY
$85.37 - $115.44 $370,505 - $501,009
4,340 Added 7.5%
62,176 $6.63 Million
Q4 2023

Feb 12, 2024

SELL
$69.51 - $104.43 $103,778 - $155,913
-1,493 Reduced 2.52%
57,836 $5.75 Million
Q3 2023

Nov 08, 2023

BUY
$96.41 - $126.61 $1.45 Million - $1.91 Million
15,077 Added 34.07%
59,329 $6.13 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $777,004 - $1.05 Million
6,557 Added 17.39%
44,252 $5.38 Million
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $254,498 - $369,609
-1,876 Reduced 4.74%
37,695 $5.79 Million
Q4 2022

Feb 08, 2023

SELL
$118.38 - $210.04 $3.88 Million - $6.88 Million
-32,773 Reduced 45.3%
39,571 $7.11 Million
Q3 2022

Nov 09, 2022

BUY
$118.07 - $194.18 $1.09 Million - $1.79 Million
9,227 Added 14.62%
72,344 $8.55 Million
Q2 2022

Aug 10, 2022

BUY
$117.13 - $176.59 $3.67 Million - $5.54 Million
31,367 Added 98.79%
63,117 $9.02 Million
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $953,508 - $1.77 Million
-7,540 Reduced 19.19%
31,750 $5.46 Million
Q4 2021

Feb 10, 2022

SELL
$225.82 - $368.51 $2.52 Million - $4.12 Million
-11,177 Reduced 22.15%
39,290 $9.98 Million
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $758,676 - $1.66 Million
-3,419 Reduced 6.34%
50,467 $19.4 Million
Q2 2021

Aug 06, 2021

BUY
$129.91 - $234.98 $1.16 Million - $2.1 Million
8,940 Added 19.89%
53,886 $12.7 Million
Q1 2021

May 10, 2021

BUY
$109.18 - $185.98 $1.25 Million - $2.13 Million
11,438 Added 34.14%
44,946 $5.89 Million
Q4 2020

Feb 10, 2021

SELL
$65.74 - $169.86 $170,792 - $441,296
-2,598 Reduced 7.2%
33,508 $3.49 Million
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $758,532 - $1.32 Million
13,959 Added 63.03%
36,106 $2.55 Million
Q2 2020

Aug 10, 2020

BUY
$29.67 - $80.0 $348,325 - $939,200
11,740 Added 112.81%
22,147 $1.42 Million
Q1 2020

May 21, 2020

BUY
$17.78 - $31.58 $185,036 - $328,653
10,407 New
10,407 $312,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.